El interés en corto de Walgreens Boots Alliance da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Walgreens Boots Alliance. Los datos de interés en corto se actualizan cada dos semanas.

Walgreens Boots Alliance (NASDAQ:WBA) Bolsa, Informe de interés en corto

Walgreens Boots Alliance

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Equities

News

Markets

AAPL

INTC

TSLA

El mercado de valores de EE.UU. cerró en positivo pese al débil crecimiento del PIB. Descubre qué acciones sorprendieron a los inversores.

Apple, Intel, Walgreens, UPS y Tesla: 5 acciones que están en el radar de los inversores

Short Ideas

Pre-Market Outlook

Trading Ideas

CHEF

Chefs&#39; Warehouse y Walgreens Boots Alliance destacan en el sector de bienes de consumo básico con altos valores de RSI.

Acciones en sobrecompra: Chefs&#39; Warehouse y Walgreens Boots Alliance en el radar

Earnings

COST

Delta, TD Synnex, Costco y otras empresas publican sus resultados trimestrales hoy. Conoce las previsiones y movimientos en el pre-market.

Acciones a seguir hoy: Delta, Costco y más reportan ganancias trimestrales

Walgreens Boots Alliance, Inc. - Common Stock

Walgreens Boots Alliance Inc

WisdomTree Trust WisdomTree Battery Value Chain and Innovation Fund

WIIM

Walgreens Boots Alliance shares are trading higher following a WSJ report suggesting the company is nearing a go-private deal with Sycamore Partners.

U.S. stock futures declined on Tuesday following the worst trading day of 2025 on Monday. Futures of all benchmark indices fell in premarket trading except Nasdaq 100.
Investor anxiety over tariffs loomed as the March 4 deadline for tariff imposition on Mexico and Canada neared. President Donald Trump indicated on Monday that there was &#8220;no room left&#8221; for tariff negotiations with Canada and Mexico. He will be addressing the Congress today, which is expected to give further clarity on tariffs and other policies.
Meanwhile, the Treasury yields slipped further on Tuesday. The 10-year Treasury yield stood at 4.16%, while the two-year yield was at 3.93%. According to the CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>, there is a 91% chance that the Federal Reserve will keep interest rates unchanged for the March meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.03%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.06%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.07%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.33%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Tuesday. SPY was up 0.046% to $584.04, and QQQ advanced 0.23% to $498.20, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
Real estate, consumer staples, health care and utilities were the only sectors that advanced on Monday. The market witnessed the second worst trading day of March ever as information technology, energy, consumer discretionary, and materials led the decline.
On the economic front, February&#8217;s S&amp;P final U.S. manufacturing PMI came in at 52.7 as compared to the preliminary reading of 51.6. This was at a 32-month high signaling an improvement in the health of the manufacturing sector.
The ISM Manufacturing PMI rose to 50.3 in February 2025, indicating a second consecutive month of slight expansion for U.S. manufacturing. In January, private residential construction spending decreased by 0.4%, with notable reductions in both multifamily construction and home improvement expenditures.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-2.64%</td>
<td>18,350.19</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.76%</td>
<td>5,849.72</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-1.48%</td>
<td>43,191.24 </td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-2.81%</td>
<td>2,102.24</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
Bearish investor sentiment surged to a near-historic 60.6% in late February, the highest in 30 months, signaling a potential contrarian buying opportunity.
Ryan Detrick of Carson Research noted that historically, stocks average a 28% gain a year after such high bearish readings, although exceptions like 2008 exist. He observed that even at a 55% bearish threshold, returns are generally strong.
Detrick suggests that barring a financial crisis, which he deems unlikely, "investors willing to stay strong and not panic sell" could see significant gains, with the S&amp;P 500 averaging nearly 13% higher in six months and 18% in a year following similar sentiment spikes.
Talking about the effects of Trump's policies on the market, the chairman and CIO of Navellier &amp; Associates, Louis Navellier said, "The volatility is certainly being fed by Trump 2.0 moves, with tariffs scheduled to be launched soon,"
Economist Jeremy Siegel, on the other hand, stated that investors are taking profits on high-flying tech and reconsidering value stocks. However, he added that slowing economic growth could hamper the value stocks as well. "In a weakening economy, all stocks face challenges, though dividend-paying and more defensive equities may benefit from lower interest rates," he added.
See Also:<a href="https://www.benzinga.com/money/how-to-trade-futures"> How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep on Tuesday:
<ul>
<li>New York Fed President John Williams will speak at 2:20 p.m. ET, whereas, Richmond Fed President Tom Barkin will speak at an undetermined time.</li>
</ul>
Stocks In Focus:
<ul>
<li>Crowdstrike Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) was up 0.34% in the premarket on Tuesday ahead of its earnings, which will be released after the opening bell. Analysts expect it to report earnings of 86 cents per share on revenue of $1,034.3 million.</li>
</ul>
<ul>
<li>Target Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) advanced 0.39% as Wall Street expects it to report quarterly earnings of $2.25 per share on revenue of $30.85 billion before the opening bell.</li>
</ul>
<ul>
<li>Green Dot Corporation. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDOT#NYSE">GDOT</a>) jumped 15.50% as it surpassed fourth-quarter earnings and revenue expectations and appointed Kim Olson as the new CFO.</li>
</ul>
<ul>
<li>Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) climbed 6.14% as private equity firm Sycamore Partners could take the company private by Thursday this week, reported WSJ.</li>
</ul>
<ul>
<li>Sacks Parente Golf Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPGC#NASDAQ">SPGC</a>) slumped 37.16% after it announced a 1-for-30 reverse stock split.</li>
</ul>
<ul>
<li>Tenaya Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNYA#NASDAQ">TNYA</a>) dropped 25.02% as the company announced plans for a public offering of units, including common stock and two warrant series, plus pre-funded units with immediately exercisable warrants.</li>
</ul>
<ul>
<li>Sphere Entertainment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) was 0.16% lower as it missed the earnings estimates.</li>
</ul>
<ul>
<li>Biodesix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) surged 18.65% after reporting a total revenue reaching $71.3 million, up 45% year-on-year.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 1.11% to hover around $67.61 per barrel.
The gold spot index was up by 0.90% to $2,919.13 per ounce. Its last record high was at $2,956.37 per ounce. The Dollar Index was down 0.46% at the 106.254 level.
Asian markets were lower on Tuesday as India's S&amp;P BSE Sensex, China's CSI 300, South Korea's Kospi, Japan's Nikkei 225, Australia's ASX 200, and Hong Kong's Hang Seng index declined. European markets were also lower in trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44070799/mark-cuban-supports-trumps-new-gold-card-scheme-if-sold-to-corporations-for-employee-citizenship-have-a-look-at-the-listed-companies-with-most-number-of-immigrants">Mark Cuban Supports Trump&#8217;s New &#8216;Gold Card&#8217; Scheme If Sold To Corporations For Employee Citizenship: Here&#8217;re The Listed-Companies With Most Number Of Immigrants</a></li>
</ul>
Photo courtesy: Shutterstock

Government

Market Summary

Futures

Commodities

Economics

Analyst Ratings

BDSX

CRWD

GDOT

SPGC

SPHR

TNYA

US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says Expert

Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) rose over 7% in premarket on Tuesday as it is on the verge of finalizing an agreement with private-equity firm Sycamore Partners to take the drugstore chain private. 
What Happened: The deal is approximately valued at $10 billion, according to a <a href="https://www.wsj.com/business/deals/walgreens-nears-roughly-10-billion-deal-to-be-go-private-ee07f2fa">report</a> by the Wall Street Journal. The two parties are reportedly aiming to complete the transaction as early as Thursday, contingent on avoiding any last-minute complications.
Discussions have centered on Sycamore Partners paying between $11.30 and $11.40 per share in cash. The potential deal may also include contingent value rights, which would provide additional value to shareholders if certain performance targets are met in the future, the report stated.
If Sycamore Partners successfully acquires the entire company, the firm intends to retain Walgreens&#8217; core U.S. retail operations. The remaining segments of the company would likely be sold off or taken public.
See Also: <a href="https://www.benzinga.com/markets/equities/25/03/44101332/sp-500-selloff-spikes-investor-pessimism-bearish-sentiment-hits-30-month-high-but-this-expert-recommends-investors-to-stay-strong-and-not-panic-sell">S&amp;P 500 Selloff Spikes Investor Pessimism: Bearish Sentiment Hits 30-Month High, But This Expert Recommends Investors To &#8216;Stay Strong And Not Panic Sell&#8217;</a>
Why It Matters: According to a mid-December <a href="https://www.benzinga.com/markets/equities/24/12/42431136/walgreens-stock-falls-over-3-in-premarket-as-wall-street-veterans-debate-private-equity-deal-value-amid-sycamore-takeover-talks">report</a> by the Wall Street Journal, Sycamore Partners was in discussions to acquire Walgreens and take the pharmacy chain private, following nearly a decade of declining stock value. 
Price Action: Walgreens fell 3.93% on Monday, underperforming the 2.76% fall in the Fidelity NASDAQ Composite Index ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEQ#NASDAQ">ONEQ</a>), which tracks the Nasdaq Composite index. It was up 7.12% in premarket on Tuesday. 
The stock remains 11.64% higher on a year-to-date basis, however, it&#8217;s down 50.15% over a year.
<a href="https://www.benzinga.com/quote/WBA/analyst-ratings">Benzinga tracks 21 analysts</a> with an average price target of $20.82 for the stock, reflecting a &#8220;sell&#8221; rating. Estimates range widely from $7 to $54. Recent ratings from Deutsche Bank, and Truist Securities average at $11.33, suggesting a potential 5.04% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/WBA/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="384" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04035828/WBA-ANR-1024x384.png" alt="" class="wp-image-807521" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04035828/WBA-ANR-1024x384.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04035828/WBA-ANR-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04035828/WBA-ANR-768x288.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04035828/WBA-ANR.png 1065w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44102004/sp-500-vs-us-dollar-while-equities-take-the-tariff-punch-greenback-sheds-tariff-fears-both">S&amp;P 500 Vs US Dollar: While Equities Take The Tariff Punch, Greenback Sheds Tariff Fears: &#8216;Both Can&#8217;t Be Right,&#8217; Says Former Goldman FX Strategist</a></li>
</ul>
Photo courtesy: Walgreens Boots Alliance

Movers & Shakers

Asset Sales

Fidelity NASDAQmposite Index Fund ETF-Tracking NASDAQmposite Index

ONEQ

Walgreens Could Go Private This Week After A $10 Billion Deal With Sycamore Partners: Report

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">B&amp;G Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGS#NYSE">BGS</a>)</h3>
<ul>
<li>Dividend Yield: 11.38%</li>
<li>Piper Sandler analyst Michael Lavery maintained a Neutral rating and slashed the price target from $8 to $7 on Feb. 26, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Barclays analyst Brandt Montour maintained an Equal-Weight rating and cut the price target from $8 to $7 on Nov. 7, 2024. This analyst has an accuracy rate of 69%.</li>
<li>Recent News: On Feb. 25, B&amp;G Foods posted better-than-expected quarterly earnings.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent030325&amp;t=be2bearmibe3na1">BGS news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent030325&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="887" height="826" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/02142434/image-1-1.png" alt="" class="wp-image-805132" style="width:567px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/02142434/image-1-1.png 887w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/02142434/image-1-1-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/02142434/image-1-1-768x715.png 768w" sizes="(max-width: 887px) 100vw, 887px" /></a></figure>
<h3 class="wp-block-heading">Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>)</h3>
<ul>
<li>Dividend Yield: 9.35%</li>
<li>Truist Securities analyst David Macdonald maintained a Hold rating and decreased the price target from $13 to $12 on Jan. 31, 2025. This analyst has an accuracy rate of 66%.</li>
<li>B of A Securities analyst Allen Lutz maintained an Underperform rating and raised the price target from $7.5 to $8.5 on Jan. 13, 2025. This analyst has an accuracy rate of 71%.</li>
<li>Recent News: Sycamore Partners is planning a buyout of Walgreens.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest WBA <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent030325&amp;t=be2bearmibe3na1">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent030325&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="900" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/02142515/image-1-2.png" alt="" class="wp-image-805133" style="width:537px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/02142515/image-1-2.png 900w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/02142515/image-1-2-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/02142515/image-1-2-768x714.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></a></figure>
<h3 class="wp-block-heading">Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>)</h3>
<ul>
<li>Dividend Yield: 7.31%</li>
<li>B of A Securities analyst Lisa Lewandowskiupgraded the stock from Neutral to Buy and increased the price target from $55 to $65 on Dec. 6, 2024. This analyst has an accuracy rate of 63%.</li>
<li>Barclays analyst Gaurav Jain maintained an Underweight rating and raised the price target from $45 to $46 on Nov. 6, 2024. This analyst has an accuracy rate of 65%.</li>
<li>Recent News: On Jan. 30, the company posted upbeat quarterly sales.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent030325&amp;t=be2bearmibe3na1">MO news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent030325&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="897" height="840" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/02142600/image-5.png" alt="" class="wp-image-805134" style="width:612px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/02142600/image-5.png 897w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/02142600/image-5-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/02142600/image-5-768x719.png 768w" sizes="(max-width: 897px) 100vw, 897px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/44041104/how-to-earn-500-a-month-from-target-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Target Stock Ahead Of Q4 Earnings</a></li>
</ul>

Dividends

Price Target

Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields

Benzinga examined the prospects for<a href="http://www.benzinga.com/trading-ideas"> many investors' favorite stocks</a> over the last week — here's a look at some of our top stories.
This week, global markets experienced significant volatility due to escalating trade tensions and disappointing tech earnings. President Trump's announcement of impending tariffs on imports from Canada, Mexico, and China led to a broad selloff in equities, with the S&amp;P 500 erasing its gains for the year.
Technology stocks were notably impacted; Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares fell sharply after underwhelming earnings, contributing to a broader decline in the semiconductor sector. Cryptocurrency markets also suffered, with Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) dropping below $80,000 amid the heightened market uncertainty.
In the fintech sector, Block Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>) led a selloff after reporting mixed fourth-quarter results, causing its stock to plunge 18% — the most significant single-day drop since March 2020. Despite the downturn, some analysts view the current valuation as an attractive entry point, anticipating growth in the company's Square and Cash App segments.
Benzinga provides daily reports on the stocks most popular with investors. Here are a few of this past week's most bullish and bearish posts that are worth another look.
The Bulls
<a href="https://www.benzinga.com/news/earnings/25/02/43993466/joby-aviation-stock-climbs-after-q4-results-heres-why">"Joby Aviation Stock Climbs After Q4 Results: Here's Why"</a>, by Erica Kollmann, reports that Joby Aviation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) posted a fourth-quarter loss of 34 cents per share, missing analyst expectations of a 20-cent loss, while revenue of $55,000 surpassed the anticipated $45,800.
<a href="https://www.benzinga.com/trading-ideas/movers/25/02/43960671/super-micro-computer-stock-is-soaring-after-hours-whats-going-on">"Super Micro Computer Stock Is Soaring After Hours: What's Going On?"</a>, by Adam Eckert, reports that Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares surged over 22% after the company filed its delayed annual and quarterly reports with the U.S. Securities and Exchange Commission.
<a href="https://www.benzinga.com/trading-ideas/movers/25/02/43929375/walgreens-boots-alliance-stock-is-up-more-than-6-on-monday-heres-what-happened">"Walgreens Boots Alliance Stock Is Up More Than 6% On Monday: Here's What Happened"</a>, by Adam Eckert, reports that Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) surged over 6% after reports that Sycamore Partners is preparing a $10 billion financing package for a potential buyout of the pharmacy giant.
For additional bullish calls of the past week, check out the following:
<a href="https://www.benzinga.com/25/02/43991166/apple-stock-to-get-a-boost-from-indonesia-iphone-16-ban-could-be-over-soon">Apple Stock To Get A Boost From Indonesia? iPhone 16 Ban Could Be Over Soon</a>
<a href="https://www.benzinga.com/news/earnings/25/02/43928216/riot-platforms-shares-climb-after-fy-2024-results-details">Riot Platforms Shares Climb After FY 2024 Results: Details</a>
<a href="https://www.benzinga.com/news/25/02/43980853/why-is-mullen-automotive-stock-skyrocketing-today">Why Is Mullen Automotive Stock Skyrocketing Today?</a>
The Bears
<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43984093/lucid-stock-falls-on-q4-results-ceo-exit-analysts-see-surge-in-demand-for-gravity-suv">"Lucid Stock Falls On Q4 Results, CEO Exit: Analysts See ‘Surge In Demand' For Gravity SUV"</a>, by Chris Katje, reports that Lucid Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) shares declined after CEO Peter Rawlinson resigned, despite analysts anticipating increased demand for the upcoming Gravity SUV.
<a href="https://www.benzinga.com/trading-ideas/technicals/25/02/44015147/nvidia-rival-amd-hits-52-week-lows-buying-opportunity-or-more-pain-ahead">"Nvidia Rival AMD Hits 52-Week Lows &#8211; Buying Opportunity Or More Pain Ahead?"</a>, by Surbhi Jain, reports that Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) shares have plummeted over 42% in the past year, hitting a 52-week low of $102.17, as bearish technical indicators overshadow strong data center growth projections.
<a href="https://www.benzinga.com/trading-ideas/technicals/25/02/44043021/tesla-the-only-magnificent-seven-stock-in-freefall-can-it-reverse-course">"Tesla: The Only Magnificent Seven Stock In Freefall &#8211; Can It Reverse Course?"</a>, by Surbhi Jain, reports that Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has declined over 25% year-to-date, making it the worst-performing stock among the Magnificent Seven, with bearish technical indicators and a high forward P/E ratio of 95.24.
For more bearish takes, be sure to see these posts:
<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43254923/7-ai-infrastructure-stocks-plunge-over-20-outpace-semiconductor-rout-as-deepseek-upends-investment-landscape">7 AI Infrastructure Stocks Plunge Over 20%, Outpace Semiconductor Rout As DeepSeek Upends Investment Landscape</a>
<a href="https://www.benzinga.com/25/02/43932271/dogecoin-gearing-for-final-leg-up-says-analyst-amid-40-slump-but-be-mindful-of-this-bearish-forecast">Dogecoin Has ‘One Final Leg Up Left,' Says Analyst Amid 40% Slump But Investors Should Be Wary Of This Bearish Forecast</a>
<a href="https://www.benzinga.com/general/market-summary/25/02/43920295/palantir-extends-losses-microsoft-slides-whats-driving-markets-monday">Palantir Extends Losses, Microsoft Slides: What's Driving Markets Monday?</a>
Keep up with all the latest breaking news and trading ideas by following <a href="https://twitter.com/Benzinga">Benzinga</a><a href="http://twitter.com/Benzinga"> on X</a>.
Image created using artificial intelligence via Midjourney.

$BTC

JOBY

LCID

NVDA

SMCI

Benzinga Bulls And Bears: Joby Aviation, Nvidia, Tesla — And Bitcoin Drops Below $80,000

<h2 class="wp-block-heading">New On The Block</h2>
Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) is seeking to sell Insitu, a maker of small, long-range military drones, per <a href="https://www.bloomberg.com/news/articles/2025-02-24/boeing-seeks-buyers-for-insitu-drone-unit-in-push-to-shed-assets">Bloomberg</a>.
The Arlington County, Virginia-based aerospace company acquired Insitu in 2008. Since then, the business has gone on to make drones for various military, including Ukraine&#8217;s. The price tag? $500 million, analysts say.
Meanwhile, BP (LSE: BP) will seek to sell its Castrol lubricants business, noted <a href="https://www.bloomberg.com/news/articles/2025-02-25/bp-said-to-prepare-lubricants-sale-ditch-plan-to-cut-oil-output-in-review?srnd=phx-deals">Bloomberg</a>. It could be worth about $10 billion &#8211; a that sum that could help strengthen the company's balance sheet, which is <a href="https://www.bloomberg.com/news/articles/2025-02-18/bp-is-said-to-weigh-sale-of-lubricants-unit-with-elliott-pushing" target="_blank" rel="noreferrer noopener">reportedly</a> weaker than its peers.
Cantaloupe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTLP#NASDAQ">CTLP</a>), a Malvern, Pennsylvania-based payments processor is exploring a sale or go-private transaction, Reuters reported. Its market cap is currently $713-million.
<h2 class="wp-block-heading">Private Equity</h2>
Sycamore Partners is planning a buyout of Walgreens (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>). If it succeeds, the firm will prepare a three-part breakup, according to the <a href="https://www.ft.com/content/9087ffb1-24d5-4adc-8a57-ef123d4c4c63">Financial Times</a>. 
The private equity firm envisions three separate businesses with distinct capital structures: the U.S. retail pharmacy, Boots UK and U.S. healthcare. Each division will operate independently.
<h2 class="wp-block-heading">Updates From The Block</h2>
Seven &amp; i (TYO:<a class="ticker" href="https://www.benzinga.com/stock/TYO:3382#TYO">3382</a>), the owner of 7-Eleven, is under pressure from Artisan Partners to consider a competitive bidding process. The retailer's response to Alimentation Couche-Tard's offer is seen as a test case for Japan's evolving M&amp;A landscape.
Seven &amp; i&#8217;s founders, the Ito family, had explored a management buyout that would have been the largest in history but ultimately failed to secure financing. Meanwhile, Couche-Tard remains committed to buying Seven &amp; i&#8217;s North American stores. But Japanese franchisees are likely to resist foreign ownership. 
Despite being deemed &#8220;core&#8221; to Japan's national security, the government has stated it would not obstruct a buyout. Separately, Seven &amp; i is close to selling non-core assets to Bain Capital, according to Reuters.
<h2 class="wp-block-heading">Off The Block</h2>
TKO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKO#NYSE">TKO</a>), created a year ago from the <a href="https://www.benzinga.com/general/entertainment/23/09/34455843/wwe-and-ufc-merge-on-tuesday-heres-what-you-need-to-know" target="_blank" rel="noreferrer noopener">merger of the WWE and UFC</a>, completed its purchase of IMG, On Location and Professional Bull Riders from Endeavor Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDR#NYSE">EDR</a>). The acquisition <a href="https://www.benzinga.com/m-a/24/10/41561859/deal-dispatch-ufc-wwe-parent-tko-takes-on-bull-riding-endeavor-looks-to-sell-tennis-another-car-comp">was first announced in October</a>.
<h2 class="wp-block-heading">Bankruptcy Block</h2>
Looks like even the aerospace industry isn't immune to crash landings. Dynamic Aerostructures, which makes high-tech parts for U.S. fighter jets and SpaceX rockets, <a href="https://www.benzinga.com/news/asset-sales/25/02/43994380/spacex-parts-supplier-dynamic-aerostructures-files-for-bankruptcy-bid-deadline-set">recently filed for bankruptcy</a>. The company plans to auction itself off in a court-supervised sale.
The company, backed by Endeavour Capital, blames its financial nosedive on quality-control issues, inflation-driven inventory costs and bad customer contracts. The search is on for a buyer, with an April 7 bid deadline set for potential suitors.
With $55 million in debt, FMI Aerostructures has been a key supplier for Boeing, Lockheed Martin and Northrop Grumman, including making parts for the stealthy B-2 Spirit bomber.
Fast fashion retailer Forever 21 is coming to a screeching halt. The company is expected to shutter all of its stores and liquidate its assets, Debtwire reports. A bankruptcy filing is not yet official. In the event that it is, expect the company&#8217;s workforce in shopping malls nationwide to feel the effects. Bloomberg projects that at least 200 locations are preparing to close.
<h2 class="wp-block-heading">Notes From The Block</h2>
M&amp;A activity is rising in digital health, biotech and provider groups as companies seek scale, data integration and new care models, according to consulting firm LBMC. Private equity-backed consolidations in healthcare services remain under scrutiny, while regulatory shifts and a new administration could reshape hospital and tech acquisitions.
Lisa Nix, LBMC shareholder, <a href="https://www.globenewswire.com/news-release/2025/02/26/3033266/0/en/LBMC-Unveils-Key-Healthcare-Trends-for-2025-AI-M-A-Cybersecurity-and-Policy-Shifts-Poised-to-Reshape-the-Industry.html">expects</a> a resurgence in healthcare M&amp;A in 2025, driven by declining interest rates, PE dry powder and a more lenient regulatory environment, setting the stage for transformative deals that could redefine patient care.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/real-estate/25/02/44004188/ellen-degeneres-and-portia-de-rossis-quest-for-a-uk-home-continues-after-their-18-million-farmhouse-purchase-runs-into-problems">Ellen DeGeneres and Portia de Rossi&#8217;s Quest For A UK Home Continues After Their $18 Million Farmhouse Purchase Runs into Problems</a></li>
</ul>

CTLP

TYO:3382

Deal Dispatch: Boeing Done With Drones? Plus BP To Sell Lubricants, 7-Eleven Parent Nixes $58 Billion Bid

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Canaccord Genuity analyst Joseph Vafi downgraded the rating for ICF International Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICFI#NASDAQ">ICFI</a>) from Buy to Hold and lowered the price target from $200 to $100. ICF International shares closed at $99.97 on Thursday. <a href="https://www.benzinga.com/quote/ICFI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird analyst Colin Sebastian downgraded Playtika Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTK#NASDAQ">PLTK</a>) from Outperform to Neutral and lowered the price target from $9 to $6. Playtika shares closed at $5.70 on Thursday. <a href="https://www.benzinga.com/quote/PLTK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities analyst Adam Angelov downgraded Logitech International S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGI#NASDAQ">LOGI</a>) from Neutral to Underperform and lowered the price target from $105 to $90. Logitech International shares closed at $101.21 on Thursday. <a href="https://www.benzinga.com/quote/LOGI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank analyst George Hill downgraded Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) from Hold to Sell and lowered the price target from $11 to $9. Walgreens shares closed at $11.23 on Thursday. <a href="https://www.benzinga.com/quote/WBA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Seaport Global analyst Tom Curran downgraded Array Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) from Buy to Neutral. Array Technologies shares closed at $6.55 on Thursday. <a href="https://www.benzinga.com/quote/ARRY/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/44018351/top-3-utilities-stocks-you-may-want-to-dump-in-february">Top 3 Utilities Stocks You May Want To Dump In February</a></li>
</ul>

Downgrades

ARRY

ICFI

LOGI

PLTK

This Walgreens Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday

Across the recent three months, 7 analysts have shared their insights on Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>), expressing a variety of opinions spanning from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $10.79, along with a high estimate of $13.00 and a low estimate of $8.50. Marking an increase of 4.15%, the current average surpasses the previous average price target of $10.36. 
<img src="https://www.benzinga.com/files/images/story/2025/1740747642_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Walgreens Boots Alliance. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>George Hill</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Sell</td>
<td>$9.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$12.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$13.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Ben Hendrix</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$12.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$12.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Allen Lutz</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$8.50</td>
<td>$7.50</td>
</tr>
<tr>
<td>Ben Hendrix</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$9.00</td>
<td>$13.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Walgreens Boots Alliance. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Walgreens Boots Alliance compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Walgreens Boots Alliance's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Walgreens Boots Alliance's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/WBA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Walgreens Boots Alliance analyst ratings.</a>
<h2>About Walgreens Boots Alliance</h2>
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
<h3>Walgreens Boots Alliance's Economic Impact: An Analysis</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Walgreens Boots Alliance displayed positive results in 3 months. As of 30 November, 2024, the company achieved a solid revenue growth rate of approximately 7.5%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Staples sector.
Net Margin: Walgreens Boots Alliance's net margin excels beyond industry benchmarks, reaching -0.67%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -2.6%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Walgreens Boots Alliance's ROA excels beyond industry benchmarks, reaching -0.33%. This signifies efficient management of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 3.09, Walgreens Boots Alliance faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Walgreens Boots Alliance: 7 Analysts Share Their Views

Deutsche Bank analyst George Hill downgrades Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) from Hold to Sell and lowers the price target from $11 to $9.

Deutsche Bank Downgrades Walgreens Boots Alliance to Sell, Lowers Price Target to $9

Walgreens Boots Alliance's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NYSE">WBA</a>) short percent of float has risen 5.57% since its last report. The company recently reported that it has 67.05 million shares sold short, which is 9.29% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.84 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Walgreens Boots Alliance Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740673829_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Walgreens Boots Alliance has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Walgreens Boots Alliance's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Walgreens Boots Alliance's peer group average for short interest as a percentage of float is 1.56%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Looking Into Walgreens Boots Alliance's Recent Short Interest

Legal

Reported February 25, 2025: Walgreens Boots Alliance Entered Into A Settlement Agreement With Everly/PWN For $595M To Resolve All Claims, Avoiding Further Litigation And Arbitration Costs, Without Admission Of Wrongdoing

Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) shares traded higher Monday following reports that multiple lenders are preparing to back a <a href="https://www.benzinga.com/general/health-care/25/02/43791793/why-is-walgreens-boots-alliance-stock-trading-higher-on-tuesday">potential buyout from</a><a href="https://www.benzinga.com/general/health-care/25/02/43791793/why-is-walgreens-boots-alliance-stock-trading-higher-on-tuesday"> Sycamore Partners</a>.
What To Know: Morgan Stanley, UBS and private lenders are reportedly putting together a $10 billion package to back Sycamore Partners&#8217; potential takeover deal for Walgreens, according to a <a href="https://x.com/OctusCredit/status/1894084066774863917">post</a> from Octus on Monday.
Sources familiar with the matter said the deal could be separated into multiple tranches and nothing has been formalized yet.
Walgreens Boots Alliance shares are up approximately 16% since the start of the year, buoyed by buyout rumors. Bloomberg<a href="https://www.bloomberg.com/news/articles/2025-02-18/walgreens-gains-after-cnbc-says-sycamore-takeout-is-alive?embedded-checkout=true"> reported</a> last week that Walgreens shares were up after CNBC&#8217;s David Faber said the deal was still &#8220;alive&#8221; after being "mostly dead a couple of weeks ago.&#8221;
The news follows <a href="https://www.benzinga.com/24/12/42421855/walgreens-stock-jumps-on-report-of-potential-private-equity-sale-what-you-need-to-know">reports</a> from December that indicated Walgreens was discussing a deal with Sycamore Partners in which the company would sell itself to the private-equity firm and pull the pharmacy chain from public markets.
Walgreens shares have been trending lower for the past 10 years. The stock was trading above $90 per share and valued at more than $100 billion in 2015. Walgreens had a market cap of $8.78 billion as of Monday's close, per <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
See Also: <a href="https://www.benzinga.com/general/health-care/25/02/43926641/hims-hers-health-stock-drops-after-q4-report-eps-in-line-revenues-beat">Hims &amp; Hers Health Stock Drops After Q4 Report: EPS In-Line, Revenues Beat</a>
WBA Price Action: <a href="http://benzinga.com/quote/wba">Walgreens shares</a> closed Monday up 6.31% at $10.80, according to data from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Movers

Walgreens Boots Alliance Stock Is Up More Than 6% On Monday: Here's What Happened

Financing

Watching Walgreens Boots Alliance; Traders Circulate Report Suggesting Company Financing For Potential Sycamore Deal

As per a media report in December, Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) suggested the company is in talks to be acquired by Sycamore Partners.
Walgreens's market value has shrunk from over $100 billion a decade ago to around $8.4 billion, as per data from <a target="_blank" href="https://www.benzinga.com/pro/feature/newsfeed" rel="noreferrer noopener">Benzinga Pro</a>.
Earlier on Tuesday, citing CNBC, the Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-02-18/walgreens-gains-after-cnbc-says-sycamore-takeout-is-alive" rel="noreferrer noopener">report</a> noted that the take-private deal with the private equity firm&nbsp;is still possible.
Walgreens Boots Alliance' deal appeared "mostly dead a couple of weeks ago," CNBC's&nbsp;David Faber&nbsp;said Tuesday. He said he was now upgrading the deal to "alive."
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43557922/debt-strategy-in-motion-walgreens-early-cencora-share-settlement-unlocks-300-million" rel="noreferrer noopener">Walgreens Cashes In: Slashes Cencora Stake Again In Debt-Fighting Move</a>
The Wall Street report in December, citing people familiar with the matter, said Sycamore would likely sell certain parts of the business or bring in partners. The people also said the deal could be <a target="_blank" href="https://www.benzinga.com/24/12/42421855/walgreens-stock-jumps-on-report-of-potential-private-equity-sale-what-you-need-to-know" rel="noreferrer noopener">completed in early 2025</a>.
Recently, the drugstore chain announced its board is suspending its cash dividend as management continues to evaluate its capital allocation policy as part of a longer-<a target="_blank" href="https://www.benzinga.com/trading-ideas/dividends/25/01/43357768/walgreens-boots-alliance-shares-slide-as-board-suspends-dividend" rel="noreferrer noopener">term turnaround strategy</a>.
In January, Walgreens reported first-quarter sales of $39.46 billion, up 7.5% year over year (+6.9% on constant currency), beating the&nbsp;consensus of $37.28 billion, reflecting sales growth across all segments.
Walgreens maintained fiscal 2025 adjusted EPS&nbsp;guidance of $1.40 – $1.80 versus the <a target="_blank" href="https://www.benzinga.com/general/health-care/25/01/42912519/walgreens-boots-alliance-stock-jumps-on-better-than-expected-q1-earnings-sticks-to-annual-profit-forecast" rel="noreferrer noopener">consensus of $1.52</a>.
The company&nbsp;expects&nbsp;growth in U.S. Healthcare and International to be offset by pressure in U.S. Retail Pharmacy, largely driven by weaker retail front-end performance.
Earlier this year,&nbsp;the U.S. Department of Justice filed a civil complaint against&nbsp;Walgreens and its subsidiaries, alleging widespread violations of the Controlled Substances Act (CSA) and <a target="_blank" href="https://www.benzinga.com/25/01/43104245/justice-department-accuses-walgreens-of-violating-drug-laws-in-opioid-epidemic-ignored-red-flags-in-opioid-crisis" rel="noreferrer noopener">False Claims Act (FCA)</a>.
The&nbsp;<a target="_blank" href="https://www.justice.gov/opa/pr/justice-department-files-nationwide-lawsuit-alleging-walgreens-knowingly-filled-millions" rel="noreferrer noopener">complaint</a> claims that Walgreens dispensed millions of unlawful prescriptions, including opioids, and sought reimbursements from federal health care programs for prescriptions that were improperly filled.
Price Action: WBA stock is up 12.1% at $10.88 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43778265/baidu-q4-earnings-ai-cloud-grows-margin-slides-expects-ai-investments-to-bear-fruit-in-2025" target="_blank" rel="noreferrer noopener">Baidu Q4 Earnings: AI Cloud Grows, Margin Slides, Expects AI Investments To Bear Fruit In 2025</a></li>
</ul>
Image via Shutterstock

Large Cap

Health Care

Rumors

General

Why Is Walgreens Boots Alliance Stock Trading Higher On Tuesday?

Walgreens shares are trading higher after reports suggesting the Sycamore takeout offer is still "alive."

<a href="https://www.bloomberg.com/news/articles/2025-02-18/walgreens-gains-after-cnbc-says-sycamore-takeout-is-alive" title="https://www.bloomberg.com/news/articles/2025-02-18/walgreens-gains-after-cnbc-says-sycamore-takeout-is-alive">https://www.bloomberg.com/news/articles/2025-02-18/walgreens-gains-after-cnbc-says-sycamore-takeout-is-alive</a>

"Walgreens Gains After CNBC Says Sycamore Takeout Is 'Alive'" - Bloomberg News

Walgreen Co Must Pay More Than $987M To Satisfy An Arbitration Award Won By Telemedicine Provider PWNHealth, A Federal Judge In Delaware Ruled On Monday.

On Thursday, Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) reached an agreement for the early settlement of certain prepaid variable share forward transactions related to shares of Cencora, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COR#NYSE">COR</a>).
As part of the early settlement, Walgreens Boots will transfer approximately 6.1 million Cencora shares to the financial institutions and make a net cash payment of about $20 million.
Alongside this, the company executed a sale of the remaining 1.3 million shares of Cencora pledged under the early settled contracts. The company receives approximately&nbsp;$300 million&nbsp;from the early settlement and the concurrent sale of shares.
Following this settlement, WBA retains 12.6 million Cencora shares under remaining prepaid contracts, set to mature primarily in March, June, and September 2025, with the potential for additional cash proceeds.
The proceeds will primarily be used for debt reduction and general corporate purposes.&nbsp;&nbsp;The transactions were scheduled to mature in March and June 2026.
By settling early and executing a concurrent share sale, WBA is realizing the embedded cash value of the prepaid variable share forwards. With this settlement, Walgreens has lowered its stake in Cencora from 10% to 6%.
Notably, Walgreens has been cutting its stake in Concera for the last few years, decreasing the stake from 12% to 10% for around <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/b40119033/walgreens-boots-alliance-sells-shares-of-cencora-for-approximately-1-1-billion-of-proceeds" rel="noreferrer noopener">$1.1 billion in August 2024</a>.
Also, in May 2024,&nbsp;Walgreens reduced ownership of Cencora shares from 13% to <a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/b38975615/walgreens-boots-alliance-sells-shares-of-cencora-for-400-million-of-proceeds" rel="noreferrer noopener">12% for approximately $400 million</a>.
These transactions, along with other recent measures such as the dividend suspension, further strengthen WBA&#8217;s ability to address its upcoming debt maturities in fiscal 2026.
Last month, the company announced it is halting its quarterly dividend while the management team reviews and adjusts its capital allocation strategy to match the company&#8217;s <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/01/43397182/whats-going-on-with-walgreens-shares-friday-2" rel="noreferrer noopener">broader long-term recovery efforts</a>.
Investors can gain exposure to the stock via Invesco High Yield Equity Dividend Achievers ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEY#NASDAQ">PEY</a>) and Invesco S&amp;P 500 Equal Weight Consumer Staples ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSPS#NYSE">RSPS</a>).
Price Action: WBA shares are up 0.40% at $10.09 premarket at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43390001/feds-favorite-inflation-gauge-rises-as-predicted-consumer-spending-jumps-at-fastest-pace-in-9-months" target="_blank" rel="noreferrer noopener">Fed&#8217;s Favorite Inflation Gauge Rises As Predicted, Consumer Spending Jumps At Fastest Pace In 9 Months</a></li>
</ul>
Image via Shutterstock.

Mid Cap

RSPS

Walgreens Cashes In: Slashes Cencora Stake Again In Debt-Fighting Move

Transaction Highlights
<ul>
<li>Walgreens Boots Alliance announces early settlement of certain prepaid variable share forward transactions with respect to shares of Cencora for delivery of an aggregate 6.1 million shares</li>
<li>Concurrent with the early settlement, the Company executed a sale of the remaining 1.3 million shares of Cencora pledged under the early settled contracts. The Company receives approximately $300 million from the early settlement and the concurrent sale of shares</li>
<li>Following today's early settlement, the Company owns approximately 12.6 million shares of Cencora pledged under the remaining prepaid variable share forward contracts, which have the potential to provide additional cash proceeds at maturity. These remaining prepaid variable share forward contracts are mainly scheduled to mature during March, June and September of calendar year 2025.</li>
<li>Use of proceeds will primarily be for debt paydown, as the Company proactively seeks to address its debt maturities in fiscal year 2026, and for general corporate purposes</li>
</ul>

Reported Earlier, Walgreens Boots Alliance Secures $300M Through Early Settlement Of Prepaid Variable Share Forward Contracts On Cencora

AMOD

Alpha Modus Files Patent Infringement Lawsuit Against Walgreens, Claiming Walgreens Infringed On Co.'s AI-Driven Retail Technology

Press Releases

Contact The Gross Law Firm by March 31, 2025 Deadline to Join Class Action Against Walgreens Boots Alliance, Inc.(WBA)

Class Action Filed Against Walgreens Boots Alliance, Inc. (WBA) - March 31, 2025 Deadline to Join – Contact Levi & Korsinsky

ROSEN, A LEADING LAW FIRM, Encourages Walgreens Boots Alliance, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WBA

Walgreens Boots Alliance, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights - WBA

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Walgreens Boots Alliance, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WBA

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in Walgreens Boots Alliance, Inc. Lawsuit - WBA

WALGREEN BOOTS ALLIANCE, INC. (NASDAQ: WBA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Walgreens Boots Alliance, Inc. Investors of Upcoming Deadline

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Walgreens Boots Alliance, Inc. and Certain Officers - WBA

Lost Money on Walgreens Boots Alliance, Inc. (WBA)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm

Investors who lost money on Walgreens Boots Alliance, Inc.(WBA) should contact Levi & Korsinsky about pending Class Action - WBA

Albertsons Companies, Inc. Class A Common Stock

Albertsons Companies

Andersons

BJ's Wholesale Club Holdings, Inc. Common Stock

BJ's Wholesale Club

Maplebear

Caseys General Stores, Inc. - Common Stock

Casey's General Stores

The Chefs' Warehouse, Inc. - Common Stock

The Chefs' Warehouse

Costco Wholesale Corporation - Common Stock

Costco Wholesale

Dollar Gen

Dollar Tree

Grocery Outlet Holding Corp. - Common Stock

Grocery Outlet Holding

Guardian Pharmacy Services, Inc. Class A Common Stock

Guardian Pharmacy Service

Ingles Markets, Incorporated - Class A Common Stock

Ingles Markets

Kroger

Natural Grocers by Vitamin Cottage, Inc. Common Stock

Natural Grocers

Performance Food Group Company Common Stock

Performance Food Gr

Pricesmart

Sprouts Farmers Market, Inc. - Common Stock

Comments

Walgreens Boots Alliance

Interés en corto

Walgreens Boots Alliance (NASDAQ:WBA) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL